Giuseppe Gargiulo

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

Pascal Vranckx, Marco Valgimigli, Lars Eckardt et al. · The Lancet · 2019 · 659 citations

Medicine, Cardiology, Pharmacology +16

Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores

Yasushi Ueki, Sarah Bär, Sylvain Losdat et al. · EuroIntervention · 2020 · 205 citations

Medicine, Cardiology, Interventional Cardiology +15

Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management

Bernardo Cortese, Filippo Russo, Martina Rothenbühler et al. · Journal of the American College of Cardiology · 2017 · 155 citations

Medicine, Cardiology, Surgery +16

Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk

Noé Corpataux, Alessandro Spirito, Felice Gragnano et al. · European Heart Journal · 2020 · 141 citations · Full text

Medicine, Cardiology, Hematology +17